Publications
- Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?2019 | Second Faculty of Medicine
- Tolerogenic dendritic cells and their application in immunopathological processes2017 | Second Faculty of Medicine
- Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms2020 | Second Faculty of Medicine
- Immune cell crosstalk in development and prevention of type 1 diabetes +12019 | Second Faculty of Medicine
- Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells2017 | Second Faculty of Medicine
- T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients2016 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- NF-kappa B, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment2015 | Second Faculty of Medicine
Loading network view...